Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice (original) (raw)
Aliskiren Normalizes Systolic Blood Pressure , Albuminuria , Glomerular Filtration Rate , and Cardiac Hypertrophy in RenTg Mice
Christos Chatziantoniou
View PDFchevron_right
Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats
Yinong Zhou
View PDFchevron_right
Renoprotective effect of aliskiren monotherapy and aliskiren−pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy
Mohammed Taha
Bulletin of Faculty of Pharmacy, Cairo University, 2013
View PDFchevron_right
Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis
Diana Rubel, Oliver Gross
American journal of hypertension, 2011
View PDFchevron_right
Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury—beyond the direct renin inhibition
Mai-szu Wu
Hypertension Research, 2012
View PDFchevron_right
Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases
Abul Najmi
Journal of Pharmacy and Pharmacology, 2012
View PDFchevron_right
Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study
Erdal Alkan, Emre Karakus
Renal Failure, 2014
View PDFchevron_right
Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats
Nahed Hassanein
Naunyn-Schmiedeberg's Archives of Pharmacology, 2016
View PDFchevron_right
Renoprotective Effects of Combined Aliskiren and Valsartan in Progressive Diabetic Nephropathy in Rats
Dr.Krishna Mohan Chinnala
International Journal of Pharmaceutical Sciences and Nanotechnology, 2011
View PDFchevron_right
Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis
Ramona Nicotera
International Urology and Nephrology, 2015
View PDFchevron_right
Aliskiren in the treatment of renal disease; a narrative review
Bijan Roshan
Journal of Parathyroid Disease
View PDFchevron_right
Direct Renin inhibitor: aliskiren in chronic kidney disease
Yoshiyuki Morishita
Nephro-urology monthly, 2013
View PDFchevron_right
Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension
Jemima Silva
International Journal of Hypertension
View PDFchevron_right
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Hans-henrik Parving
New England Journal of Medicine, 2008
View PDFchevron_right
Renoprotective Effects Aliskiren on Adenine-induced Tubulointerstitial Nephropathy: Possible Underlying Mechanisms
Hala Malek
Canadian Journal of Physiology and Pharmacology, 2016
View PDFchevron_right
Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats
H. Korashy
Journal of the Renin-Angiotensin-Aldosterone System, 2014
View PDFchevron_right
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats
Sonia Gandhi
Journal of the Renin-Angiotensin-Aldosterone System, 2012
View PDFchevron_right
Protective effects of aliskiren and valsartan in mice with diabetic nephropathy
Jeffrey Kopp
Journal of the renin-angiotensin-aldosterone system : JRAAS, 2014
View PDFchevron_right
Renin Inhibition Reverses Renal Disease in Transgenic Mice by Shifting the Balance Between Profibrotic and Antifibrotic Agents
AHmed ABed
Hypertension, 2013
View PDFchevron_right
The Antihypertensive and Renoprotective Efficacy of Aliskiren: Results of Every Other Day Administration
Rigas Kalaitzidis
Journal of Hypertension, 2011
View PDFchevron_right
Safety of enhanced renin–angiotensin–aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
Przemysław Rutkowski
Polish Archives of Internal Medicine, 2013
View PDFchevron_right
Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients
P.J. Blankestijn
Nephrology Dialysis Transplantation, 2011
View PDFchevron_right
Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Vjekoslav Gerc
Medical Archives, 2009
View PDFchevron_right
Effect of Aliskiren on Renal Cortical Ischemia/Reperfusion Injury in Albino Rats: A Histological and Immunohistochemical Study
Alshaymaa Aboulkhair
Egyptian Journal of Histology
View PDFchevron_right
Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury
Abul Najmi
Journal of the Renin-Angiotensin-Aldosterone System, 2013
View PDFchevron_right
Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
William Dole
Circulation, 2008
View PDFchevron_right
Aliskiren inhibits experimental venous thrombosis in two-kidney one-clip hypertensive rats
Adam Hermanowicz
Thrombosis research, 2012
View PDFchevron_right
The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study
Chi-bon Leung
PLoS ONE, 2013
View PDFchevron_right
Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney
mohamed essam
Life Sciences, 2021
View PDFchevron_right
Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
Hans-henrik Parving
Diabetes Care, 2009
View PDFchevron_right